A UAE-based professor has made significant strides in the field of targeted drug delivery for cancer treatment. Dr. Ghaleb Husseini, a professor of pharmaceutical sciences at the University of Sharjah, has developed a novel approach that could improve the effectiveness of chemotherapy drugs while minimizing the side effects.
The current standard chemotherapy treatment delivers drugs throughout the entire body, including healthy cells, which often leads to unpleasant side effects such as hair loss, nausea, and fatigue. Dr. Husseini’s method involves using nanoparticles to target only cancer cells, leaving healthy cells unharmed. This approach increases the effectiveness of the drugs while reducing the severity of side effects.
Dr. Husseini’s research has been ongoing for over a decade, and he has received support from various sources, including the National Research Foundation and the Emirates Foundation. He has also collaborated with international researchers to test and refine his method.
In a recent study, Dr. Husseini and his team tested the effectiveness of their method on mice with breast cancer. They found that the nanoparticles were able to deliver the chemotherapy drugs directly to the cancer cells, significantly reducing tumor size without causing any major side effects.
The breakthrough has the potential to revolutionize cancer treatment, providing a more effective and targeted approach that could improve patient outcomes and quality of life. Dr. Husseini and his team are currently working to further develop and refine their method before moving on to clinical trials.
Dr. Husseini’s innovative approach to targeted drug delivery has garnered attention from the scientific community and has been published in several prestigious journals, including the Journal of Controlled Release and the International Journal of Pharmaceutics.
Overall, Dr. Husseini’s research represents a significant step forward in the fight against cancer, and his contributions to the field of targeted drug delivery could have far-reaching implications for future cancer treatments.
